CIK 0001422143 · Non-accelerated filer<br>Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 611547851
- Phone
- (858) 500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $1,239,000
- in 1 filing
- Open-market sales, last 90 days
- $1,708,041
- in 8 filings, $650K under 10b5-1 plans
Net −$469,041. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$1.2M President and CEO 1 filing
- Bair Teresa Brophy −$486K Chief Legal Officer sold 18% of stake
- Leoni Mollie −$440K Chief Medical Officer sold 23% of stake
- Powl Brian T. −$397K Chief Commercial Officer sold 21% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Bair Teresa Brophy Chief Legal Officer | Grant or award · Option to purchase common stock | +100,000 | 100,000 | ||
| 2025-12-18 | Burrows Francis Chief Scientific Officer | Option exercise | +35,000 | $4.80 | $168K | 57,461 |
| 2025-12-18 | Burrows Francis Chief Scientific Officer | Sale | −23,726 | $9.78 | $232K | 33,735 |
| 2025-12-18 | Burrows Francis Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −35,000 | 0 | ||
| 2025-12-09 | Hasnain Faheem Director | Option exercise | +10,000 | $3.12 | $31K | 33,983 |
| 2025-12-09 | Hasnain Faheem Director | Sale | −10,000 | $10.98 | $110K | 23,983 |
| 2025-11-14 | Bair Teresa Brophy Chief Legal Officer | Sale 10b5-1 | −8,804 | $11.18 | $98K | 188,139 |
| 2025-11-14 | Powl Brian T. Chief Commercial Officer | Sale | −8,887 | $11.18 | $99K | 139,689 |
| 2025-11-14 | Leoni Mollie Chief Medical Officer | Sale | −15,485 | $11.18 | $173K | 225,454 |
| 2025-11-14 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Sale | −4,539 | $11.18 | $51K | 130,257 |
| 2025-11-14 | FORD KATHLEEN Chief Operating Officer | Sale 10b5-1 | −6,902 | $11.18 | $77K | 105,373 |
| 2025-11-13 | Bair Teresa Brophy Chief Legal Officer | Grant or award 10b5-1 | +48,900 | 196,943 | ||
| 2025-11-13 | WILSON TROY EDWARD President and CEO | Grant or award | +182,500 | 429,353 | ||
| 2025-11-13 | Powl Brian T. Chief Commercial Officer | Grant or award | +48,900 | 148,576 | ||
| 2025-11-13 | Leoni Mollie Chief Medical Officer | Grant or award | +82,500 | 240,939 | ||
| 2025-11-13 | DOYLE THOMAS JAMES SVP, Finance & Accounting | Grant or award | +24,967 | 134,796 | ||
| 2025-11-13 | FORD KATHLEEN Chief Operating Officer | Grant or award 10b5-1 | +48,900 | 112,275 | ||
| 2025-09-29 | Powl Brian T. Chief Commercial Officer | Sale | −8,891 | $8.94 | $80K | 99,676 |
| 2025-09-29 | Bair Teresa Brophy Chief Legal Officer | Sale 10b5-1 | −8,805 | $8.94 | $79K | 148,043 |
| 2025-09-29 | FORD KATHLEEN Chief Operating Officer | Sale 10b5-1 | −6,892 | $8.94 | $62K | 63,375 |
Page 4 of 9 · 164 trades